# Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).

Study · id `cardio:ct-nct04788186` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04788186](<https://clinicaltrials.gov/study/NCT04788186>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04788186

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT04788186. Randomized; no masking; primary purpose treatment. Start 2021-08-23 (actual); primary completion 2024-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT04788186, source copy `cardio:ctgov-nct04788186-2022-11-09`, retrieved 2026-10-26)
- Started: 2021-08-23 (actual) (ClinicalTrials.gov record NCT04788186, source copy `cardio:ctgov-nct04788186-2022-11-09`, retrieved 2026-10-26)
- Primary completion: 2024-08-31 (anticipated) (ClinicalTrials.gov record NCT04788186, source copy `cardio:ctgov-nct04788186-2022-11-09`, retrieved 2026-10-26)
- Completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT04788186, source copy `cardio:ctgov-nct04788186-2022-11-09`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04788186, source copy `cardio:ctgov-nct04788186-2022-11-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04788186-2022-11-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).
- Acronym: BEEFBURGER
- Condition: Coronary Artery Disease
- Condition: Acute Myocardial Infarction
- Condition: Coronary Artery Stenosis
- Condition: ST Elevation Myocardial Infarction
- Condition: Non-ST Elevation Myocardial Infarction (NSTEMI)
- Intervention (Drug): De-prescribe beta blocker therapy
- Lead sponsor: University of Saskatchewan
- Lead sponsor class: OTHER
- Collaborator: Canadian VIGOUR Centre
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: University of Saskatchewan (`cardio:org-university-of-saskatchewan`)
- Registry lists this organization as a collaborator: Canadian VIGOUR Centre (`cardio:org-canadian-vigour-centre`)

## Provenance

Content hash: 7dcd92e7abdfeab1f9083899ad13480dadc53cf3dbe56f854a8b0c45bc3d471b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
